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controlled trial1–3
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ABSTRACT
Background: Previous investigations suggest continuous tube
feeding (TF) schedules do not suppress appetite and food intake, but
bolus TF has been little studied.
Objective: We tested the hypothesis that 1) bolus TF does not
suppress appetite and food intake and 2) there is no interrelation
between food intake and appetite mediators (including ghrelin).
Design: A single-blind, placebo-controlled trial within which 6
healthy men [body mass index (in kg/m2): 21.1 1.61] received 3 d
of bolus TF (6.930.38 MJ/d of 4.18 kJ/mL multinutrient feed). For
2 d before and after TF, placebo boluses (0.4 MJ/d) were given by
tube. Hourly tracking of appetite, weighed measurements of daily ad
libitum food intake, and metabolic and hormonal (including ghrelin)
measurements were undertaken.
Results: Total energy intake was significantly increased with bolus
TF (18.2 1.86 MJ; P 0.0005) despite a partial reduction in food
intake compared with placebo periods (P0.013) and during the TF
period (by 15%; P 0.007). There was little change in hunger and
fullness with bolus TF, and within-day temporal patterns did not
differ whether TF or placebo was given. Changes in fasting concen-
trations of ghrelin (1003.6–756.0 pmol/L; P  0.013) and other
mediators (including leptin, insulin, and glucose) were significantly
related to subsequent daily food intake (eg, ghrelin: r2 0.81, P
0.022).
Conclusions: In this short-term study, subjects maintained appetite
ratings during bolus TF by a significant reduction in food intake and
changes in ghrelin and some appetite mediators related to subsequent
daily food intake. Longer-term studies are required to fully ascertain
the effect of TF on appetite, food intake, and appetite
mediators. Am J Clin Nutr 2008;88:77–83.
INTRODUCTION
Tube feeding (TF) is a common method of treatment of mal-
nourished patients and patients at risk of becoming malnourished
as a result of swallowing difficulties, unconsciousness, and se-
vere critical illness in clinical practice (1, 2). However, TF of
liquid feeds directly into the stomach by a nasogastric tube
(which bypasses the cephalic phase response) is also a powerful
means to explore concepts of appetite control relevant to both
undernutrition and obesity. TF enables investigation of the effect
of providing energy and nutrients in liquid form over a period of
time while bypassing the sensory aspects of oral consumption
(taste, smell, mouthfeel) and the cephalic phase response. Stud-
ies in patients receiving TF suggest disturbances in appetite sen-
sations (3, 4). In addition, although TF is used as a supplement to
food intake in 50% of patients, it is uncertain whether TF
suppresses appetite and replaces energy taken orally or whether
TF provides additional energy to aid in the treatment of the
undernourished patient. Controlled study of the effect of TF on
appetite control in healthy subjects has been infrequently used
because of difficulties recruiting volunteers who may be reluc-
tant to be exposed to the inconvenience of nasogastric tube in-
sertion, of keeping the tube in situ for several days or weeks, and
for the restriction of physical activity during pump-assisted feed-
ing. However, with the recent advent of portable lightweight
infusion pumps this last issue is much less of a problem. We have
previously shown that 3-d administration of liquid feeds provid-
ing a mixture of macro- and micronutrients (continuously over
12–24 h) is well tolerated (as are fine-bore nasogastric tubes kept
in situ for longer than a week). Importantly, this study also sug-
gested that continuous TF did not suppress appetite and food
intake (5). However, the effects of intermittent tube feeding with
boluses of feed (which are more physiologic than slow, contin-
uous infusions over 12–24 h) has not been addressed. It is pos-
sible that bolus TF may also fail to induce satiety as liquid feeds
are administered and the upper gastrointestinal tract and the
associated cephalic phase response [with a role in preabsorptive
control of appetite (6–8)] are bypassed. Alternatively, it could be
that the intermittent delivery of nutrients as boluses, reflecting a
more physiologic meal-like pattern, suppresses appetite and food
intake to a much greater extent than does a slow continuous liquid
infusion of nutrients over time. Although a few studies have
examined the effect of liquid bolus TF on appetite or food intake
(9–11), these have typically involved short infusions (3.5 h) of
single macronutrients (as opposed to multinutrient liquid feeds)
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or were poorly controlled (confounded by changes in physical
activity or disease) and have failed to consider appetite and food
intake, together with changes in putative appetite mediators [in-
cluding circulating concentrations of hormones (eg, ghrelin, lep-
tin, insulin), metabolites (eg, glucose) etc]. Therefore, this
single-blind, placebo-controlled trial tested the hypothesis that
liquid TF delivered intermittently as boluses by nasogastric tube
over days suppresses appetite and ad libitum food intake (unlike
continuous TF schedules) by effects on a range of metabolic and
hormonal mediators of appetite and satiety.
SUBJECTS AND METHODS
Subjects, setting, and ethical approval
Six healthy, adult male, nonsmoking subjects, none of whom
were taking medication, were recruited from a volunteer data-
base and from advertisements in university colleges to take part
in the study [(x  SD) age: 33  8.4 y; weight: 67.7  7.2 kg;
body mass index (in kg/m2): 21.1 1.61; with stable weight for
1 y (2 kg); body fat: 19.1  3.7%). The entire study was
conducted in a metabolic suite to control for the effect of physical
activity on appetite and food intake. Ethical approval was ob-
tained for this study from the Local Research Ethics Committee,
and subjects gave their informed consent before taking part. All
subjects completed the study.
Protocol
This study was a single-blind, placebo-controlled design. A
fine-bore nasogastric tube (Freka 8F, 120 cm; Fresenius, War-
rington, United Kingdom) was inserted at the start of the 9-d
study, to give subjects 2 d to become accustomed to it (days 1–2).
During these 2 d (days 1–2), subjects were given a fixed “main-
tenance” diet to consume orally [energy content equivalent to 1.5
times predicted basal energy expenditure (BEE) (12), 10.67 
0.68 MJ] to facilitate energy balance with nothing given by
nasogastric tube. For the remainder of the study (days 3–9),
boluses were given by the nasogastric tube of a placebo for 2 d
before (days 3–4) and after (days 8–9) 3 d of a feed (days 5–7).
During days 5–7, a liquid, fiber-free tube feed was given (6.93
0.38 MJ; 15% energy from protein, 49% carbohydrate, 35% fat;
4.18 kJ/mL; vitamins, minerals, and trace elements; Nutrison,
Nutricia, Trowbridge, United Kingdom), the daily energy con-
tent of which was equivalent to 1 times predicted BEE (12). The
tube feed was administered intermittently as 4 boluses, each
during a 20-min period (average volume: 415 23.5 mL; aver-
age rate: 0.09 MJ/min) at the following times during the day:
0900, 1230, 1600, and 1930. For the 2 d before (days 3–4) and
after (days 8–9) TF, a placebo (colored water; energy provision
0.4 MJ) was given. This had a similar appearance to the tube
feed and was given as boluses in identical volumes, at the same
rate, and at the same times of day as the tube feed. On questioning
subjects at the end of the study, they were unaware of the use of
a placebo feed. Throughout days 3–9, subjects consumed ad
libitum covertly manipulated food items that each were isoener-
getically dense (550 kJ/100 g) and had the same macronutrient
composition (40% energy from fat, 47% from carbohydrate, and
13% from protein). There were 11 different food items available
daily as part of a 3-d rotating menu cycle (menu A, B, and C,
started on day 3 in random order for each subject) [see Stubbs et
al (13) for more details]. All food was preprepared in excess and
kept in a refrigerator designated to each subject, and a microwave
oven was available for heating food when required. Subjects had
free access to caffeine-free beverages throughout the study pe-
riod.
Measurements
The following measurements were undertaken.
Food intake
Subjects were asked to record the timing of food and drink
consumption in a food diary, and a weighed food inventory was
performed to assess daily (24 h) oral energy intake and its dis-
tribution through the day on days 3–9. Assessment of the energy
intake orally from covertly manipulated foods was undertaken
with the use of the RONA computer package, created by the
Rowett Research Institute, Aberdeen, United Kingdom, and
based on the Royal Society of Chemistry’s Composition of
Foods database (14). Assessment was made of the pleasantness
and satisfying nature of the food after each meal with the use of
a visual analogue scale (VAS) (scored from 0 mm to 100 mm for
the least to the most pleasant and satisfying) (15). The Dutch
Eating Behavior Questionnaire to assess dietary restraint was
completed by all subjects at the end of the study (16).
Appetite sensations
Subjects rated their appetite sensations each waking hour of
every day of the study with the use of paper VAS questionnaires.
The questionnaire consisted of 6 VASs to rate “hunger,” “full-
ness,” “desire to eat,” “how much can you eat now?,” “urge to
eat,” and “preoccupation with thoughts of food” (15, 17). Each
subject was given a booklet of questionnaires (containing one
questionnaire for each hour) and a small hourly timer to remind
them to complete it.
Anthropometry
Body weight was measured (digital platform scale accurate to
within 0.001 kg; Sauter, Ebingen, Germany) at the same time on
each morning of the study after voiding, and height was measured
with the use of a stadiometer (Karimetre; Raven Equipment
Limited, Dunmow, Essex, United Kingdom) at the start of the
study. Body mass index (in kg/m2) was calculated, and measure-
ments of skinfold thickness at 4 sites (triceps, biceps, suprailiac,
subscapular) were undertaken, and the percentage of fat was
calculated (18) at the start of the study (day 1) and at the end of
the following study periods: after the maintenance diet (before
TF started; day 3), after 2 d of placebo bolus TF (day 5), and after
3 d of bolus TF (day 8), in line with previous study methods (5).
Results were not divulged to the subjects.
Indirect calorimetry: respiratory quotient and resting energy
expenditure (days 3, 5, and 8)
Resting energy expenditure (REE) was measured at the same
time of the morning (0815) on day 3 (after the maintenance
period before TF started), day 5 (after 2 d of placebo TF), and day
8 (after bolus TF period), in line with previous study methods (5).
The ventilated hood technique was used with a Deltatrac Meta-
bolic Monitor (MBM-100; Datex Instrumentarium Corp, Hel-
sinki, Finland), and all measurements were conducted at room
temperature (23  1 °C). After a 30-min warm-up period, the
Deltatrac was calibrated with standard gases, and pressure and
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basal measurements were begun (without the subject) until the
machine was equilibrated. Subjects were recumbent for mea-
surement of their metabolic rate, having just woken in the morn-
ing and were fasting. They were asked to relax, but not sleep, and
lie still with their arms by the side of their body with legs un-
crossed during the measurement. The ventilated hood (made of
clear plastic and ventilated with a constant flow of air 40
L/min) was placed over the subject’s head to measure inspired
and expired gases. Oxygen consumption, carbon dioxide pro-
duction, and respiratory exchange rates (RQ) were obtained ev-
ery minute for 30 min, and REE was calculated (19). On com-
pletion of the measurement period (30 min), the hood was
removed from over the subject’s head, and further basal mea-
surements (without the subject) were collected. Finally, calibra-
tion of gases and pressure were rechecked. The accuracy of the
Deltatrac (98–100% of predicted values) was checked periodi-
cally with the use of nitrogen (80%) and carbon dioxide (20%)
infusions (measured with the use of an oil-filled gas meter type
DM3A; Alexander Wright and Co, London, United Kingdom) (20).
Blood sampling for the measurement of metabolites and
hormones in the fasted state (days 3, 5, and 8)
After measurement of REE, early morning on day 3 (after
completion of the 2-d maintenance period), day 5 (after the pla-
cebo period), and day 8 (after the 3-d TF period), venous fasting
blood samples were taken for the measurement of plasma con-
centrations of the following hormones: ghrelin (radioimmuno-
assay; Linco Research Inc, St Louis, MO), leptin (radioimmu-
noassay; Linco Research Inc), insulin (enzyme amplified
sensitivity immunoassay; Biosource Europe SA, Nivelles, Bel-
gium), cholecystokinin (radioimmunoassay; Euro-Diagnostica,
Malmo, Sweden), and glucagon (radioimmunoassay; Euro-
Diagnostica); and the following metabolites: glucose (Gluc HK,
Unimate 5; Roche Diagnostica Instruments, Basel, Switzerland),
glycerol (Boehringer Mannheim GmbH, Mannheim, Germany),
lactate (21), -hydroxybutyrate (21), nonesterified fatty acids
(NEFAs; Wako Alpha Laboratories, Eastleigh, United King-
dom), and triacylglycerol (Unimate 5 TRIG kit; Roche Diagnos-
tica Instruments).
Statistical methods
Repeated-measures analysis of variance (ANOVA) was un-
dertaken on data that were normally distributed. Time (day) was
the within-subject factor. Post hoc analysis with the use of poly-
nomial contrasts (eg, linear, quadratic) enabled statistical anal-
ysis of 1) linear effects across time (days 3–9, days 3–4, days 5–7,
days 8–9) and 2) the quadratic effect (comparison of the TF
period with the colored water periods collectively). Two-factor
repeated-measures ANOVA with deviation contrasts was used to
compare the individual, within-day, hourly ratings of hunger and
fullness with the daily grand mean. Parametric data are presented
as mean  SD. To calculate the correlation coefficients for re-
peated metabolic measurements, energy intake, and appetite,
analysis of covariance was used. These analyses were undertaken
on normally distributed data, and data were presented as mean
SD. Leptin concentrations, which required log transformation to
normalize the positively skewed distribution, were presented as
geometric mean SD (the antilog of the mean of logged data
1 SD of logged data). For nonnormally distributed data, analyses
were performed with the use of Friedman’s k-related samples for
repeated measurements and Wilcoxon’s signed rank test (paired
comparisons), and data were presented as median (range). Sta-
tistical analysis was performed with the use of SPSS, version
11.5 (SPSS Inc, Chicago, IL). Sample size calculations based on
the intraindividual variability in food intake for 2-d periods (SD:
12%; 1.67 MJ) suggested that 6 subjects were required to detect
a 20% change in food intake (2.8 MJ) with 80% power and a
significance of P 0.05.
RESULTS
All subjects (n 6) completed the study. Bolus TF was well
tolerated, and there were no reports of abdominal pain, changes
in bowel frequency, or diarrhea.
Food (oral) and total (oral  tube) energy intake
Bolus TF for 3 d universally increased total (oral  tube)
energy intake to 18.2  1.86 MJ compared with the placebo
periods before and after TF (Figure 1; P  0.0005). Overall,
food (oral) intake was significantly reduced with bolus TF com-
pared with the placebo periods (Figure 1; P  0.013). This
suppression of food intake with bolus feeding was equivalent to
39.7% (2.75 MJ) of the tube feed energy infused, leaving 60.3%
(4.18 MJ) additive to oral energy intake. During the 3-d bolus TF
period, food energy intake significantly declined (by 15%) to
9.94  1.99 MJ, so that only 40% of the tube feed energy was
additive (Figure 1). During the 2 placebo periods (days 3–4, days
8–9), no significant differences were observed in food (oral) or
total (oral tube) intake.
Morning (up to 1300) and afternoon (1300–1700) food energy
intakes were no different during the bolus TF period (days 5–7)
from when the placebo was given by tube (days 3–4 and days
8–9). Evening food energy intakes (after 1700) were signifi-
cantly lower during the bolus TF period (4.81  1.54 MJ) than
during placebo periods (days 3–4: 6.29  2.39 MJ; days 8–9:
0
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FIGURE 1. Food (oral) and total (oral tube) energy intake (in MJ) with
bolus enteral tube feeding. *Significant increase in total (oral tube) energy
intake (P  0.0005) and significant decrease in food (oral) energy intake
compared with placebo periods (P  0.013), repeated-measures ANOVA,
quadratic contrasts; significant reduction in food (oral) energy intake during
bolus TF, P  0.007, repeated-measures ANOVA, linear contrasts; dotted
line represents oral energy intake on last day of TF (day 7); data are presented
as mean SD (n 6).
TUBE FEEDING, FOOD INTAKE, AND SATIETY 79
 by guest on June 17, 2011
w
w
w
.ajcn.org
D
ow
nloaded from
 
6.22  2.34 MJ; P  0.02, repeated-measures ANOVA, qua-
dratic contrasts) and progressively decreased daily during the 3 d
of TF (P 0.04, repeated-measures ANOVA, linear contrasts).
Results from the Dutch Eating Behavior Questionnaire sug-
gested that 2 subjects were restrained eaters (dietary restraint
score  20) (16). When the 2 restrained eaters were excluded
from the analysis (dataset n  4), there remained a significant
increase in total energy intake with bolus TF (17.7  1.90 MJ)
compared with the placebo periods before and after TF (P 
0.01). There remained a reduction in food (oral) intake (P0.06)
compared with placebo periods, and during the 3-d bolus feeding
period there remained a reduction in food intake (12%).
Food pleasantness and satisfaction ratings
No significant difference was observed during the bolus TF
study (days 3–9) in the daily pleasantness (mean daily scores:
63–71 mm) or satisfaction ratings (69–75 mm) for food. The
pleasantness and satisfaction ratings of the food consumed with
the 3 different menus (A, B, and C) did not differ significantly
(eg, pleasantness scores: menu A, 68 13 mm; menu B, 72 11
mm; menu C, 66 13 mm; satisfaction scores: menu A, 72 9
mm; menu B, 72  13 mm; menu C, 72  12 mm), and no
significant differences were observed in oral energy intake ac-
cording to menu (A, B, and C).
Appetite sensations
No significant differences were observed in the first hour VAS
ratings of appetite sensations across the study period as a whole
or during the bolus TF period specifically. The only exception
was the preoccupation with thoughts of food ratings, which var-
ied significantly during the bolus TF period (P 0.0, repeated-
measures ANOVA). Median daily scores for each of the appetite
sensations did not differ significantly during the bolus TF period
(days 5–7) or throughout the whole study period, except for
preoccupation with thoughts of food scores (P  0.001, Fried-
man’s k-related samples test). For simplicity, the median results
for each of the appetite sensations for the 3 study periods are
presented in Table 1. During 3 d of bolus TF, within-day hunger
and fullness ratings varied significantly, but no differently to
when only placebo boluses were given as shown in Figure 2.
Anthropometry
After the maintenance period (days 1–2), a significant change
was observed in body weight (1.82 0.89 kg) across the study
period as a whole (P 0.002, repeated-measures ANOVA, lin-
ear contrasts). Although the change in body weight during the
bolus TF period was not significant (P  0.08), it was signifi-
cantly different from the placebo periods (P  0.04, repeated-
measures ANOVA, quadratic contrasts). During the study a sig-
nificant increase was observed in mid upper arm circumference
(P 0.02) but not in percentage of body fat (18).
Relations between the metabolic and hormonal changes
associated with bolus TF, hunger, and food intake shortly
after the time of measurement
Changes in the following measured mediators of appetite dur-
ing bolus TF (Table 2) related positively (ghrelin: r2 0.81, P
 0.022; NEFAs: r2 0.87, P 0.002) or negatively (leptin: r2
 0.87, P 0.002; insulin: r2 0.81, P 0.014; glucose: r2
0.77, P 0.049; glucagon: r2 0.79, P 0.03; RQ: r2 0.86,
P 0.004) to the daily food (oral) energy intake (on day 3: 14.56
 3.09 MJ; day 5: 11.68 2.02 MJ; and day 8: 11.91 2.87 MJ,
analysis of covariance). No such relation was found between
cholecystokinin, triacylglycerol, lactate, -hydroxybutyrate, or
REE and daily energy intake. None of the changes in mediators
related to or hence predicted appetite (eg, first hour hunger) or
food intake (morning energy intake) shortly after the measure-
ments were made.
DISCUSSION
This investigation presents the first controlled study in humans
assessing the effect of boluses given by nasogastric tube (daily
energy provision equivalent to 1 times BEE) on food intake,
appetite sensations, and putative appetite mediators, including
ghrelin. Liquid feeds delivered by tube (bypassing the upper
gastrointestinal tract and the associated cephalic phase response)
significantly increased total energy intake. However, as hypoth-
esized, the delivery of boluses significantly reduced food intake,
compared with placebo periods (before and after TF) and during
the 3-d bolus TF period (Figure 1). This contrasts with the de-
livery of feed continuously by tube (12–24-h schedules during
the day or night), which we have previously shown does not
significantly reduce food intake (5). It is likely that delivering the
same quantity of feed in a more “physiologic” intermittent way
with bolus TF during the day (0.09 MJ/min) would suppress food
intake more than a slow continuous infusion over many hours
(particularly overnight infusions during sleep). This may be be-
cause bolus feeding elicits greater metabolic, hormonal, and ther-
mogenic responses involved in satiation. In particular, it was
evening food intake (after 1700) that was suppressed, with morn-
ing and afternoon intakes unaffected.
The design of the study (with placebo periods before and after
TF) also allowed us to confirm that there was no suggestion of
volume effects or effects of the method of feeding per se (eg,
subjects being more conscious of having boluses during the day)
causing the reduced food intake. Similarly, the subjects were
given time to become accustomed to the nasogastric tube before
TF commenced. Therefore, a possible explanation, as hypothe-
sized, is that liquid boluses given by tube are more satiating than
continuous TF infusions, reducing appetite sensations. In this
short study we found no differences in appetite sensations (24 h,
first hour of the day, hourly within day), whether subjects were
bolus fed or given a placebo. As indicated in Figure 2, even the
hourly tracked hunger and fullness sensations were no different
TABLE 1
Appetite sensations for each study period during the bolus tube feeding
study1
Bolus placebo
(days 3–4)
Bolus feed
(days 5–7)
Bolus placebo
(days 8–9)
Hunger 34 (0–77) 32 (0–86) 33 (6–82)
Fullness 51 (2–94) 49 (5–92) 43 (0–87)
Desire to eat 33 (0–87) 32 (0–82) 31 (4–84)
How much can you eat now? 41 (3–79) 40 (0–85) 38 (3–84)
Urge to eat 31 (0–82) 28 (0–80) 30 (0–84)
Preoccupation with thoughts
of food2
31 (0–82) 28 (0–78) 26 (0–81)
1 Rated with visual analogue scale (in mm). All values are median; range
in parentheses; n 6.
2 P 0.001 (Friedman’s k-related samples).
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whether the bolus given was a placebo or feed. This suggests that
persons maintain the same degree of hunger and most other
appetite sensations during bolus feeding by eating significantly
less (only ratings of “preoccupation with thoughts of food” var-
ied significantly with no clear pattern during the study period).
The differences in food intake observed with TF may partly be
explained by changes in appetite mediators, a variety of which
were investigated. In the present study, the marked increase in
total energy intake with bolus TF (Figure 1) was associated with
a significant increase in some of the putative satiety mediators
measured (leptin, insulin, glucagon, RQ, REE) (22) and a reduc-
tion in the appetite stimulant ghrelin (see Table 2). Studies have
suggested that ghrelin, a 28 amino acid growth hormone secre-
tagogue, is suppressed by meals, and intravenous infusions of
ghrelin increase food intake and appetite (23, 24). For the first
time, this study has longitudinally assessed ghrelin, and other
appetite mediators, in relation to changes in food intake and
appetite sensations in those receiving bolus TF. Fasting ghrelin
concentrations during the study significantly related to subse-
quent (24 h) food intake. Similarly, changes in fasting circulating
concentrations of leptin, NEFAs, insulin, glucose, and glucagon
and changes in RQ significantly related to the change in 24-h
food intake, at least within the time frame of this study. This
contrasts with previous investigations of continuous TF regi-
mens in which changes in a variety of appetite mediators did not
relate to changes in daily food intake (5, 25). Notably, with all
schedules (bolus and continuous), no relation was found between
any of the measured appetite mediators and measures of appetite
or food intake shortly after the measurements. To more fully
understand the effect of changes in putative mediators of appetite
during different TF schedules and subsequent appetite sensations
and food intake, more frequent measurements of these metabolic
or hormonal variables during the day and night are required and
for longer study periods.
Although bolus TF elicited a variety of metabolic changes
associated with the significant reduction in food intake observed,
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FIGURE 2. Similar within-day changes in hunger and fullness during bolus tube feeding (days 5–7) and placebo periods (days 3–4, 8–9). Within-day ratings
of hunger and fullness during bolus TF and placebo periods: P 0.001, repeated-measures ANOVA; n 6.
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total energy intake was still markedly increased. The reduction in
food intake with bolus TF was only equivalent to 40% of TF
energy during this 3-d period, producing a small increase in body
weight but no detectable change in percentage of body fat. Sub-
stantial increments in total energy intake also occurred with
continuous TF of liquids, because neither appetite nor food in-
take was reduced (5). In both cases the increment in total energy
intake may be facilitated by delivering nutrients by tube, thereby
bypassing the cephalic phase response and upper gastrointestinal
tract. The short duration of feeding (3 d) might also be a factor,
and studies of a longer duration are warranted. The delivery of
nutrients as a liquid is also likely to be important. Although
intervention studies do not conclusively show that liquids given
orally are less satiating than solids (26), the rise in consumption
of energy-rich drinks has been linked to the obesity epidemic
(27). Although the liquid feed used in this study was a multinu-
trient, milk-based feed, studies of similar feeds given orally also
suggest little effect on appetite or on voluntary food intake (2).
Therefore, it appears that liquids given by tube (with no oral or
upper gastrointestinal contact or sensory influences) are a par-
ticularly effective way of increasing total energy and nutrient
intake, at least in the short term. Not only is this an important
observation about liquids and appetite control, but it also has
implications for the clinical use of liquids and TF as a means of
nutritional support (2). In particular, the study provides impor-
tant insights for those persons who receive supplementary enteral
feeding. For such persons who receive TF as a supplement to
food intake, this study suggests bolus schedules are less effective
than continuous schedules at increasing total energy or nutrient
intake, with greater suppression of food intake. Consequently,
bolus TF may be more useful in those persons in whom food
intake is contraindicated for long periods of time. However,
before definitive conclusions can be made, the limitations of the
present study need to be acknowledged. These include the sub-
ject group (healthy men, including 2 restrained eaters), its sample
size (n 6), the controlled environment of the metabolic suite,
and the short duration of bolus TF (3 d). Therefore, there is a need
for further investigation in larger groups of healthy subjects and
in patients (both men and women) in controlled and clinical
settings to address more fully the effects of both bolus and con-
tinuous TF of liquids on appetite and food intake. Longer term
trials are also indicated, because an increasing number of patients
are fed artificially by tube for long periods of time (1, 28) and to
gain greater insights into liquids and appetite control. Further-
more, the current trial specifically investigated supplementary
TF because food intake was one of the key outcome variables. It
did not address the effects of TF as a sole source of nutrition on
appetite. Although our earlier studies indicate distressing appe-
tite sensations in patients receiving TF as a sole source of nutri-
tion (3, 4), a more controlled study that also assesses appetite
mediators is required.
In summary, this is the first placebo-controlled investigation
of the effect of short-term bolus TF on a variety of appetite
mediators, appetite sensations, and food intake in the absence of
confounding factors such as disease (29). Bolus TF universally
and significantly increased total (oral tube) energy intake, with
60% of tube feed energy additional to that taken orally. Appe-
tite sensations remained largely unaffected by the additional
energy from liquid bolus TF because subjects ate significantly
less compared with placebo periods and during the 3-d course of
feeding. Accompanying the reductions in food intake was a sig-
nificant decline in circulating ghrelin concentrations and
changes in a range of other putative appetite signals. Although
this pilot study in healthy men suggests that bolus TF is well
TABLE 2
Circulating hormone and metabolite concentrations, respiratory quotient, and resting energy expenditure (REE) during bolus tube feeding (TF) study1
After 2-d maintenance
diet (day 3)
After 2-d bolus TF
of placebo (day 5)
After 3-d bolus TF
of feed (day 8) P2
Hormones
Ghrelin (pmol/L) 1003.6 239.83 904.0 234.7 756.0 259.5 0.013
Leptin (g/L)4 2.63 1.82 3.55 1.55 4.37 1.74 0.0005
Insulin (IU/mL) 7.27 2.07 9.28 2.35 13.2 5.04 0.004
CCK (pmol/L) 25.4 14.6 23.0 15.1 23.9 14.8 NS
Glucagon (pmol/L) 28.0 5.67 31.4 9.38 36.3 7.86 0.001
Metabolites
Glucose (mmol/L) 4.90 0.34 5.02 0.15 5.17 0.35 NS
NEFAs (mol/L) 404 149 309 217 278 178 0.002
Triacylglycerol (mmol/L) 1.11 0.49 1.03 0.36 1.26 0.38 NS
Glycerol (mol/L) 115 51 109 41 118 29 NS
Lactate (mol/L) 1044 327 1232 352 1331 204 NS
-Hydroxybutyrate (mol/L)5 54 (26–79) 56 (35–122) 54 (31–74) NS
Indirect calorimetry
Respiratory quotient 0.83 0.03 0.90 0.07 0.95 0.05 0.0005
REE (MJ/24 h) 6.74 0.56 6.75 0.73 7.27 0.63 0.02
1 n 6. Measurements undertaken (early morning) on day 3 after the 2-d maintenance diet (days 1–2) had finished, before the bolus placebo period started
(days 3–4); day 5 after the 2-d bolus placebo period (days 3–4) had finished, before the bolus feeding period started; day 8 after the 3-d bolus feeding period
(days 5–7) had finished, before the final bolus placebo period started (days 8–9). CCK, cholecystokinin; NEFAs, nonesterified fatty acids; NS, not significant
(P 0.05).
2 Determined with repeated-measures ANOVA (day 3 compared with day 5 compared with day 8).
3 x  SD (all such values).
4 Values are geometric x  SD (see Methods for explanation).
5 Data were not normally distributed, and values are presented as median with range in parentheses, analyzed with Friedman’s k-related samples.
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tolerated and may be more satiating than a continuous TF sched-
ule, longer term studies, including investigations in the clinical
setting, are required to fully ascertain the implications for the
effect of liquids on appetite control and for the use of this method
of feeding in the clinical setting.
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